VanEck Vectors Pharmaceutical ETF (PPH)

59.68
Delayed Data
As of 3:59pm ET
 -0.04 / -0.07%
Today’s Change
53.31
Today|||52-Week Range
64.65
+0.62%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible- before fees and expenses- the price and yield performance of the MVIS- US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Invest Like Warren Buffett With These ETFs
Feb 20 / Zacks.com - Paid Partner Content
Solid Q4 Earnings Drive Pharma ETF Outlook
Feb 09 / Zacks.com - Paid Partner Content

Performance

1 month-4.71% 3 years-2.66%
3 months+7.60% 5 years+9.09%
1 year+10.17% Since inception+10.95%
Data through 02/21/2018

Quote Details

Previous close$59.72
Open day’s range59.67 – 60.64
Net asset value (NAV)59.72 (02/20/2018)
Daily volume32,471
Average volume (3 months)120,580
Data as of 3:59pm ET, 02/21/2018

Peer Comparisonvs. Health ETFs

 PPHCategory
Performance 5-yr return+9.09%+17.28%
Expense Gross exp ratio0.40%1.31%
Risk 5 year sharpe ratio0.741.11
Net assets$266.7M$3.2B
Average market cap$46.6B$9.5B
Average P/E20.422.6
Dividend / Share--0.34%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
TEVA Teva Pharmaceutical6.08%
ABBV AbbVie5.63%
MRK Merck5.03%
AZN AstraZeneca5.00%
NVS Novartis4.97%
GSK GlaxoSmithKline4.96%
MYL Mylan NV4.79%
ABC AmerisourceBergen Corp4.75%
PFE Pfizer4.73%
BMY Bristol-Myers Squibb4.71%